Transmitted drug resistance among HIV-1 drug-naïve patients in Greece
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 105, 42-48
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Estimation of causal effects of binary treatments in unconfounded studiesStatistics in Medicine, 2015
- Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-AnalysisPLOS Medicine, 2015
- Global burden of transmitted HIV drug resistance and HIV-exposure categoriesAIDS, 2014
- Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assayJournal of Antimicrobial Chemotherapy, 2014
- Short Communication: Molecular Epidemiology of HIV Type 1 Infection in Northern Greece (2009–2010): Evidence of a Transmission Cluster of HIV Type 1 Subtype A1 Drug-Resistant Strains Among Men Who Have Sex with MenAIDS Research and Human Retroviruses, 2014
- Prevalence in the Usa of Rilpivirine Resistance-Associated Mutations in Clinical Samples and Effects on Phenotypic Susceptibility to Rilpivirine and EtravirineAntiviral Therapy, 2013
- Combining Multiple Imputation and Inverse‐Probability WeightingBiometrics, 2011
- Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing RegimensJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- The HIV Type 1 Epidemic in Bulgaria Involves Multiple Subtypes and Is Sustained by Continuous Viral Inflow from West and East European CountriesAIDS Research and Human Retroviruses, 2008
- Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsThe Lancet, 2007